84540-59-0

Basic information

• Product Name: 4-Methyl-3-nitrobenzyl chloride
• Synonyms: 4-METHYL-3-NITROBENZYL CHLORIDE;3-NITRO-4-METHYLBENZOYLCHLORIDE;3-NITRO-P-TOLUYL CHLORIDE;TIMTEC-BB SBB007967;4-(chloromethyl)-2-nitrotoluene;4-METHYL-3-NITROBENZYL CHLORIDE 97%;Benzene, 4-(chloromethyl)-1-methyl-2-nitro- (9CI);4-(Chloromethyl)-1-methyl-2-nitrobenzene
• CAS NO: 84540-59-0
• Molecular Formula: C₈H₈ClNO₂
• Molecular Weight: 185.61
• EINECS: 283-154-3
• Product Categories: HALOMETYL;M;Stains and Dyes;Stains&Dyes, A to
• Mol File: 84540-59-0.mol

Chemical Properties

• Melting Point: 46 °C
• Boiling Point: 87 °C
• Flash Point: >230 °F
• Appearance: /
• Density: 1.37 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.000218mmHg at 25°C
• Refractive Index: n20/D 1.581(lit.)
• CAS DataBase Reference: 4-Methyl-3-nitrobenzyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-3-nitrobenzyl chloride(84540-59-0)
• EPA Substance Registry System: 4-Methyl-3-nitrobenzyl chloride(84540-59-0)

Safety Data

• Hazard Codes: C
• Statements: 34-36/37
• Safety Statements: 26-27-36/37/39-45-28
• RIDADR: UN 3265 8/PG 2
• WGK Germany: 3
• Hazardous Substances Data: 84540-59-0(Hazardous Substances Data)

Usage

Chemical Properties

yellow crystalline powder or chunks

InChI:InChI=1/C8H8ClNO2/c1-6-2-3-7(5-9)4-8(6)10(11)12/h2-4H,5H2,1H3

Upstream product

• 7697-37-2 nitric acid 
• 108-24-7 acetic anhydride 
• 104-82-5 4-Methylbenzyl chloride 
• 7446-70-0 aluminium trichloride 
• 88-72-2 1-methyl-2-nitrobenzene 
• 107-30-2 chloromethyl methyl ether 
• 542-88-1 bis(2-chloromethyl)ether 
• 7664-93-9 sulfuric acid 
• 104-87-0 4-methyl-benzaldehyde 
• 31680-07-6 4-methyl-3-nitrobenzaldehyde 
• 19910-92-0 3,3'-dinitro-4,4'-dimethylbenzophenone 
• 76947-17-6 4,4'-dimethyl-3,3'-dinitrodiphenylmethane 
• 4957-14-6 4,4'-dimethyldiphenylmethane 
• 40870-59-5 (4-Methyl-3-nitro-phenyl)-methanol 

Downstream Products

• 143032-53-5 C-Chloro-N-(4-methyl-3-nitro-benzyl)-N-phenyl-methanesulfonamide 
• 610-29-7 2-nitroterephthalic acid 
• 95-78-3 2,5-Dimethylaniline 
• 101207-48-1 2-(4-methyl-3-nitrobenzyl)isoindoline-1,3-dione 
• 623155-53-3 4-methyl-3-nitro-benzylamine 
• 623155-55-5 C₁₁H₁₄N₂O₄ 
• 623155-54-4 C₁₁H₁₆N₂O₂ 
• 1019779-04-4 GW 791343 
• 309712-84-3 4-(3-{2-[-tert-Butoxycarbonyl-(3,4-difluoro-phenyl)-amino]-acetylamino}-4-methyl-benzyl)-piperazine-1-carboxylic acid tert-butyl ester 
• 309712-83-2 4-(3-amino-4-methyl-benzyl)-piperazine-1-carboxylic acid tert-butyl ester 
• 1420998-14-6 4-ethoxymethyl-1-methyl-2-nitro-benzene 
• 1420998-29-3 4-methoxymethyl-1-methyl-2-nitro-benzene 
• 1420997-69-8 C₂₀H₁₉N₅O₃*ClH 

Relevant articles and documents

HETEROARYL COMPOUNDS AS INHIBITORS OF PROGRAMMED NECROSIS PATHWAY, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to the programmed necrosis pathway.

NEW SUBSTITUTED CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS

The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF- KB-inducing kinase (NIK - also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.